Renee P. Tannenbaum, Director at Cardiff Oncology, Inc. (CRDF), bought 10,000 shares at $3.42 ($34K) on 2024-12-12, disclosed to the SEC on 2024-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRDF | BUY | 2022-09-19 | $17K | — | Filing → |
| ZGNX | SELL | 2021-11-30 | $124K | — | Filing → |
| ZGNX | BUY | 2021-06-03 | $85K | — | Filing → |